バイオ医薬品受託製造（BCMO）の世界市場 2020年

• 英文タイトル：Global Biopharmaceutical Contract Manufacturing(BCMO) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113707 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、バイオ医薬品受託製造（BCMO）の世界市場を調査対象にし、バイオ医薬品受託製造（BCMO）の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（哺乳類ベース製造、微生物ベース製造、その他）、用途別分析（バイオ製薬会社、製薬会社、創薬会社、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Lonza Group Ltd、ProBioGen AG、Fujifilm Diosynth Biotechnology、Boehringher Ingelheim、BIOMEVA GmbH、Sandoz、Celonic GmbH、Rentschler Biotechnologie ・企業別売上、市場シェア ・バイオ医薬品受託製造（BCMO）の地域別市場分析 ・バイオ医薬品受託製造（BCMO）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・バイオ医薬品受託製造（BCMO）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・バイオ医薬品受託製造（BCMO）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・バイオ医薬品受託製造（BCMO）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・バイオ医薬品受託製造（BCMO）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・バイオ医薬品受託製造（BCMO）の種類別市場規模2015-2020：哺乳類ベース製造、微生物ベース製造、その他 ・バイオ医薬品受託製造（BCMO）の用途別市場規模2015-2020：バイオ製薬会社、製薬会社、創薬会社、その他 ・バイオ医薬品受託製造（BCMO）の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Biopharmaceutical Contract Manufacturing(BCMO) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Biopharmaceutical Contract Manufacturing(BCMO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Biopharmaceutical Contract Manufacturing(BCMO) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Biopharmaceutical Contract Manufacturing(BCMO) market has been segmented into:
Mammalian Based Manufacturing
Microbial Based Manufacturing
Other

By Application, Biopharmaceutical Contract Manufacturing(BCMO) has been segmented into:
Bio-Pharmaceutical Companies
Pharmaceutical Companies
Drug Discovery Companies
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biopharmaceutical Contract Manufacturing(BCMO) market presented in the report. This section sheds light on the sales growth of different regional and country-level Biopharmaceutical Contract Manufacturing(BCMO) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biopharmaceutical Contract Manufacturing(BCMO) market.

The report offers in-depth assessment of the growth and other aspects of the Biopharmaceutical Contract Manufacturing(BCMO) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Biopharmaceutical Contract Manufacturing(BCMO) Market Share Analysis
Biopharmaceutical Contract Manufacturing(BCMO) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biopharmaceutical Contract Manufacturing(BCMO) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biopharmaceutical Contract Manufacturing(BCMO) sales, revenue and market share for each player covered in this report.

The major players covered in Biopharmaceutical Contract Manufacturing(BCMO) are:
Lonza Group Ltd
ProBioGen AG
Fujifilm Diosynth Biotechnology
Boehringher Ingelheim
BIOMEVA GmbH
Sandoz
Celonic GmbH
Rentschler Biotechnologie

レポート目次

---

Table of Contents

1 Biopharmaceutical Contract Manufacturing(BCMO) Market Overview
1.1 Product Overview and Scope of Biopharmaceutical Contract Manufacturing(BCMO)
1.2 Classification of Biopharmaceutical Contract Manufacturing(BCMO) by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type in 2019
1.2.3 Mammalian Based Manufacturing
1.2.4 Microbial Based Manufacturing
1.2.5 Other
1.3 Global Biopharmaceutical Contract Manufacturing(BCMO) Market by Application
1.3.1 Overview: Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Bio-Pharmaceutical Companies
1.3.3 Pharmaceutical Companies
1.3.4 Drug Discovery Companies
1.3.5 Other
1.4 Global Biopharmaceutical Contract Manufacturing(BCMO) Market by Regions
1.4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biopharmaceutical Contract Manufacturing(BCMO) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biopharmaceutical Contract Manufacturing(BCMO) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical Contract Manufacturing(BCMO) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical Contract Manufacturing(BCMO) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biopharmaceutical Contract Manufacturing(BCMO) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical Contract Manufacturing(BCMO) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Lonza Group Ltd
2.1.1 Lonza Group Ltd Details
2.1.2 Lonza Group Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Lonza Group Ltd SWOT Analysis
2.1.4 Lonza Group Ltd Product and Services
2.1.5 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2018-2019)
2.2 ProBioGen AG
2.2.1 ProBioGen AG Details
2.2.2 ProBioGen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ProBioGen AG SWOT Analysis
2.2.4 ProBioGen AG Product and Services
2.2.5 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Fujifilm Diosynth Biotechnology
2.3.1 Fujifilm Diosynth Biotechnology Details
2.3.2 Fujifilm Diosynth Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Fujifilm Diosynth Biotechnology SWOT Analysis
2.3.4 Fujifilm Diosynth Biotechnology Product and Services
2.3.5 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringher Ingelheim
2.4.1 Boehringher Ingelheim Details
2.4.2 Boehringher Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringher Ingelheim SWOT Analysis
2.4.4 Boehringher Ingelheim Product and Services
2.4.5 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2018-2019)
2.5 BIOMEVA GmbH
2.5.1 BIOMEVA GmbH Details
2.5.2 BIOMEVA GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 BIOMEVA GmbH SWOT Analysis
2.5.4 BIOMEVA GmbH Product and Services
2.5.5 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sandoz
2.6.1 Sandoz Details
2.6.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sandoz SWOT Analysis
2.6.4 Sandoz Product and Services
2.6.5 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Celonic GmbH
2.7.1 Celonic GmbH Details
2.7.2 Celonic GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Celonic GmbH SWOT Analysis
2.7.4 Celonic GmbH Product and Services
2.7.5 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Rentschler Biotechnologie
2.8.1 Rentschler Biotechnologie Details
2.8.2 Rentschler Biotechnologie Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Rentschler Biotechnologie SWOT Analysis
2.8.4 Rentschler Biotechnologie Product and Services
2.8.5 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceutical Contract Manufacturing(BCMO) Players Market Share
3.2.2 Top 10 Biopharmaceutical Contract Manufacturing(BCMO) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Market Share by Regions
4.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
4.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
4.5 South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
5 North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries
5.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries (2015-2020)
5.2 USA Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
5.3 Canada Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
5.4 Mexico Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
6 Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries
6.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries (2015-2020)
6.2 Germany Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
6.3 UK Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
6.4 France Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
6.5 Russia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
6.6 Italy Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries
7.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries (2015-2020)
7.2 China Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
7.3 Japan Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
7.4 Korea Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
7.5 India Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
8 South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries
8.1 South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries (2015-2020)
8.2 Brazil Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
8.3 Argentina Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biopharmaceutical Contract Manufacturing(BCMO) by Countries
9.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
9.3 UAE Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
9.4 Egypt Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
9.5 South Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Market Share by Type (2015-2020)
10.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast by Type (2019-2024)
10.3 Mammalian Based Manufacturing Revenue Growth Rate (2015-2025)
10.4 Microbial Based Manufacturing Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Segment by Application
11.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Application (2015-2020)
11.2 Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast by Application (2019-2024)
11.3 Bio-Pharmaceutical Companies Revenue Growth (2015-2020)
11.4 Pharmaceutical Companies Revenue Growth (2015-2020)
11.5 Drug Discovery Companies Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Forecast (2021-2025)
12.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Forecast (2021-2025)
12.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast by Regions (2021-2025)
12.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
12.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
12.6 South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biopharmaceutical Contract Manufacturing(BCMO) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Lonza Group Ltd Corporate Information, Location and Competitors
Table 6. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Major Business
Table 7. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Total Revenue (USD Million) (2017-2018)
Table 8. Lonza Group Ltd SWOT Analysis
Table 9. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 10. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. ProBioGen AG Corporate Information, Location and Competitors
Table 12. ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Major Business
Table 13. ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Total Revenue (USD Million) (2018-2019)
Table 14. ProBioGen AG SWOT Analysis
Table 15. ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 16. ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Fujifilm Diosynth Biotechnology Corporate Information, Location and Competitors
Table 18. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Major Business
Table 19. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Total Revenue (USD Million) (2017-2018)
Table 20. Fujifilm Diosynth Biotechnology SWOT Analysis
Table 21. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 22. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Boehringher Ingelheim Corporate Information, Location and Competitors
Table 24. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Major Business
Table 25. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Total Revenue (USD Million) (2017-2018)
Table 26. Boehringher Ingelheim SWOT Analysis
Table 27. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 28. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. BIOMEVA GmbH Corporate Information, Location and Competitors
Table 30. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Major Business
Table 31. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Total Revenue (USD Million) (2017-2018)
Table 32. BIOMEVA GmbH SWOT Analysis
Table 33. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 34. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sandoz Corporate Information, Location and Competitors
Table 36. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Major Business
Table 37. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Total Revenue (USD Million) (2017-2018)
Table 38. Sandoz SWOT Analysis
Table 39. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 40. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Celonic GmbH Corporate Information, Location and Competitors
Table 42. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Major Business
Table 43. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Total Revenue (USD Million) (2017-2018)
Table 44. Celonic GmbH SWOT Analysis
Table 45. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 46. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Rentschler Biotechnologie Corporate Information, Location and Competitors
Table 48. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Major Business
Table 49. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Total Revenue (USD Million) (2017-2018)
Table 50. Rentschler Biotechnologie SWOT Analysis
Table 51. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 52. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) by Players (2015-2020)
Table 54. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Players (2015-2020)
Table 55. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Regions (2015-2020)
Table 57. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries (2015-2020)
Table 58. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries (2015-2020)
Table 59. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Countries (2015-2020)
Table 62. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries (2015-2020)
Table 65. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) by Type (2015-2020)
Table 66. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Type (2015-2020)
Table 67. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Forecast by Type (2021-2025)
Table 68. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2015-2020)
Table 69. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Application (2015-2020)
Table 70. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Forecast by Application (2021-2025)
Table 71. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biopharmaceutical Contract Manufacturing(BCMO) Picture
Figure 2. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type in 2019
Figure 3. Mammalian Based Manufacturing Picture
Figure 4. Microbial Based Manufacturing Picture
Figure 5. Other Picture
Figure 6. Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Application in 2019
Figure 7. Bio-Pharmaceutical Companies Picture
Figure 8. Pharmaceutical Companies Picture
Figure 9. Drug Discovery Companies Picture
Figure 10. Other Picture
Figure 11. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share in 2019
Figure 20. Global Top 10 Players Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Regions (2015-2020)
Figure 24. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Regions in 2018
Figure 25. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 26. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 28. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 30. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries (2015-2020)
Figure 31. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries in 2019
Figure 32. USA Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 33. Canada Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 35. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries in 2019
Figure 37. Germany Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 38. UK Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 39. France Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 40. Russia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 41. Italy Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries in 2019
Figure 44. China Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 45. Japan Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 46. Korea Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 47. India Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 49. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries (2015-2020)
Figure 50. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries in 2019
Figure 51. Brazil Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 56. UAE Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2015-2020)
Figure 59. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Type (2015-2020)
Figure 60. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Type in 2019
Figure 61. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share Forecast by Type (2021-2025)
Figure 62. Global Mammalian Based Manufacturing Revenue Growth Rate (2015-2020)
Figure 63. Global Microbial Based Manufacturing Revenue Growth Rate (2015-2020)
Figure 64. Global Other Revenue Growth Rate (2015-2020)
Figure 65. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Application (2015-2020)
Figure 66. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Application in 2019
Figure 67. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share Forecast by Application (2021-2025)
Figure 68. Global Bio-Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 69. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 70. Global Drug Discovery Companies Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
Figure 76. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
Figure 78. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---